173 related articles for article (PubMed ID: 30356125)
21. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
[TBL] [Abstract][Full Text] [Related]
24. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
25. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
Usman M; Faruqui ZS; ud Din N; Zahid KF
J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
[TBL] [Abstract][Full Text] [Related]
26. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours.
O'Sullivan JM; Huddart RA; Norman AR; Nicholls J; Dearnaley DP; Horwich A
Ann Oncol; 2003 Jan; 14(1):91-6. PubMed ID: 12488299
[TBL] [Abstract][Full Text] [Related]
27. Non-seminomatous testicular germ cell tumours in Denmark 1976-1980. Results of treatment.
von der Maase H; Engelholm SA; Rørth M; Sandberg Nielsen E; Schultz HP; Svennekjaer IL; Vaeth M
Acta Radiol Oncol; 1984; 23(4):255-61. PubMed ID: 6208747
[TBL] [Abstract][Full Text] [Related]
28. Scuba diving post-bleomycin therapy: a case report.
Gray RN
Undersea Hyperb Med; 2010; 37(6):455-7. PubMed ID: 21226396
[TBL] [Abstract][Full Text] [Related]
29. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
30. [Testicular malignant tumours. Efficacy of germ cell and sex cord tumours treatment protocol in Poland].
Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
Med Wieku Rozwoj; 2006; 10(3 Pt 1):811-7. PubMed ID: 17317912
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the predictive value among inflammation-based scoring systems for bleomycin pulmonary toxicity in patients with germ cell tumors.
Maruyama Y; Sadahira T; Araki M; Mitsui Y; Wada K; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Int J Urol; 2019 Aug; 26(8):813-819. PubMed ID: 31115106
[TBL] [Abstract][Full Text] [Related]
32. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
[No Abstract] [Full Text] [Related]
33. Safety and efficacy of bleomycin/pingyangmycin-containing chemotherapy regimens for malignant germ cell tumor patients in the female genital system.
Zhao Q; Cao D; Yu M; Yang J; Liu Y; Xiang Y; Wu M; Pan L; Lang J; Xu K; Han J; Shen K
Oncotarget; 2017 Feb; 8(9):15952-15960. PubMed ID: 28160575
[TBL] [Abstract][Full Text] [Related]
34. Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours.
Bosl GJ; Leitner SP; Atlas SA; Sealey JE; Preibisz JJ; Scheiner E
Int J Androl; 1987 Feb; 10(1):353-7. PubMed ID: 2438226
[TBL] [Abstract][Full Text] [Related]
35. Poor prognosis germ cell tumors of the testes: improved results with high dose regimens.
Ozols RF
Prog Clin Biol Res; 1988; 269():419-27. PubMed ID: 2455910
[No Abstract] [Full Text] [Related]
36. The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
Stoter G; Denis L
Acta Urol Belg; 1985; 53(2):428-40. PubMed ID: 2409785
[No Abstract] [Full Text] [Related]
37. Non-seminomatous germ cell tumours of the testis: game and set but not match.
Thomson DB; Walpole ET; Grimes D
Aust N Z J Med; 1991 Dec; 21(6):835-6. PubMed ID: 1726357
[No Abstract] [Full Text] [Related]
38. [Effectiveness of chemotherapy by the AVM protocol (adriamycin, vincristine and methotrexate) after unsuccessful treatment of patients with non-seminoma using PVB (cisplatin, vinblastine and bleomycin)].
Madej G; Siedlecki P; Pieńkowski T
Nowotwory; 1984; 34(4):329-34. PubMed ID: 6085587
[No Abstract] [Full Text] [Related]
39. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
Huddart SN; Mann JR; Gornall P; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendsus KR
J Pediatr Surg; 1990 Apr; 25(4):406-10. PubMed ID: 1691781
[TBL] [Abstract][Full Text] [Related]
40. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
